Anticancer online medicine | Millionpharma

POMYELO 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomyelo 4mg and it belongs to anti-neoplastic drugs Pomyelo 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomyelo 4mg c ombination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomyelo 4mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomyelo 4mg capsules is used by combining with dexamethasone. Pomyelo 4mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomyelo 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomyelo has three primary pharmacological

BEVATAS GLIOBLASTOMA MULTIFORME DESCRIPTION Bevacizumab is a drug sold under the name of Bevatas and which is categorized as monoclonal anti-body & anti-angiogenesis  When Bevatas 100mg concomitant use with human monoclonal antibody IgG1, that circumstance and prohibits the biological action of human vascular endothelial growth factor (VEGF) USAGE Bevatas 100mg is indicated for the treatment of some of the conditions like Metastatic colon or rectal cancer Non-squamous, non-small cell lung cancer Glioblastoma Metastatic renal cell cancer Metastatic cervical cancer Epithelial ovarian, fallopian tube or peritoneal cancer MECHANISM OF ACTION Bevatas 100mg Injection comprises an active compound like Bevacizumab which binds to VEGF and avoid the communication of VEGF to its receptors like Flt-1 & KDR) present on the surface of the cells This interaction prevents endothelial cell multiplication and new blood vessel production occurs Hence in counts cessation

POMAHOPE 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 4mg and it belongs to anti-neoplastic drugs Pomahope 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 4mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 4mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 4mg Capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi

POMAHOPE 3MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 3mg and it belongs to anti-neoplastic drugs Pomahope 3mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 3mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 3mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 3mg capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 3mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi

POMAHOPE 2MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 2mg and it belongs to anti-neoplastic drugs Pomahope 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 2mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 2mg is used by combining with dexamethasone. Pomahope 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 2mg capsules treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activitie

POMAHOPE 1MG POMAHOPE 1MG DESCRIPTION Pomalidomide is sold under the brand name Pomahope 1mg and it belongs to anti-neoplastic drugs Pomahope 1mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 1mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 1mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 1mg capsules is used by combining with dexamethasone. Pomahope 1mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 1mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological ac

ZELGOR 500MG PROSTATE CANCER DESCRIPTION Zelgor 500mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands. Normally this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulating the production of tumors in prostate. Zelgor 500mg is an anti-androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. Brand :Zelgor Ingredients : Abiraterone acetate Strength : 500mg Manufactured : Sun Pharmaceuticals Ltd Package : 60 tablets PHARMACOKINETICS Absorption of tablet Zelgor 500mg:   Time to median plasma concentration of tablet Zelgor 500mg takes 12 hours. Distribution

ZELGOR PROSTATE CANCER DESCRIPTION Zelgor 250mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands.  Normaly this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulates the production of tumors in prostate. Zelgor 250mg tablet is an anti androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. PHARMACOKINETICS ABSORPTION Time to median plasma concentration of tablet Zelgor 250mg takes 12 hours. DISTRIBUTION Maximum bound to the human plasma protein like albumin and alpha-1 acid glycoprotein. METABOLISM The main two metabolites of Abiraterone in human plasma are

ZECYTE 500MG PROSTATE CANCER DESCRIPTION Zecyte 500mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands. Normally this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulating the production of tumors in prostate. Zecyte 500mg is an anti-androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. Brand :Zecyte Ingredients : Abiraterone acetate Strength : 500mg Manufactured : Glenmark Pharmaceuticals Ltd Package : 60 tablets PHARMACOKINETICS Absorption of tablet Zecyte 500mg Tablets :  Time to median plasma concentration of tablet Zecyte 500mg takes 12 hours. 

ZECYTE PROSTATE CANCER DESCRIPTION Zecyte 250mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands.  Normaly this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulates the production of tumors in prostate. Zecyte 250mg tablet is an anti androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. PHARMACOKINETICS ABSORPTION Time to median plasma concentration of tablet Zecyte 250mg takes 12 hours. DISTRIBUTION Maximum bound to the human plasma protein like albumin and alpha-1 acid glycoprotein. METABOLISM The main two metabolites of Abiraterone in human plasma are

ABIRAPRO 500MG PROSTATE CANCER DESCRIPTION Abirapro 500mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands. Normally this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulating the production of tumors in prostate. Abirapro 500mg is an anti-androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. Brand :Abirapro Ingredients : Abiraterone acetate Strength : 500mg Manufactured : Glenmark Pharmaceuticals Ltd Package : 60 tablets PHARMACOKINETICS Absorption of tablet Abirapro 500mg tablet :  Time to median plasma concentration of tablet Abirapro 500mg takes 12

ABIRAPRO PROSTATE CANCER DESCRIPTION Abirapro 250mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands.  Normaly this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulates the production of tumors in prostate. Abirapro 250mg is an anti androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. PHARMACOKINETICS ABSORPTION Time to median plasma concentration of tablet Abirapro 250mg tablet takes 12 hours. DISTRIBUTION Maximum bound to the human plasma protein like albumin and alpha-1 acid glycoprotein. METABOLISM The main two metabolites o

                                             POMACEL 2MG DESCRIPTION Pomalidomide is sold under the brand name Pomacel 2mg and it belongs to anti-neoplastic drugs Pomacel 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomacel 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomacel 2mg Capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomacel 2mg capsules is used by combining with dexamethasone. Pomacel 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomacel 2mg capsules treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomacel ha

LENALID 25MG MYELODYSPLASTIC SYNDROME DESCRIPTION Lenalid 25mg contains Lenalidomide as an active substance which belongs to thalidomide analogue. Lenalid 25mg contains some pharmacological activities like immuno modulatory, anti-neoplastic, & anti-angiogenesis. Lenalid 25mg is available in various strengths like 5mg, 10mg, 15mg & 25mg. Lenalid 25mg is a prescription medicine; used under the supervision of medical oncologist. Lenalid 25mg is used by combining with dexamethasone. INDICATION The most common indications of Lenalid 25mg tablet are; Multiple myeloma: Lenalid 25mg should be used in combination with dexamethasone. Myelodysplastic syndrome: Lenalid 25mg is used to treat this condition Mantle cell lymphoma: Lenalid 25mg is used for this condition, if patients are not responding to the Bortezomib treatment. MECHANISM Lenalid 25mg tablet includes in the restraint of tumor rot factor alpha arrangement, which support the T-cells and causes lessen

LENALID 5MG MYELODYSPLASTIC SYNDROME DESCRIPTION Lenalid 5mg contains Lenalidomide as an active substance which belongs to thalidomide analogue. Lenalid 5mg contains some pharmacological activities like immuno modulatory, anti-neoplastic, & anti-angiogenesis. Lenalid 5mg is available in various strengths like 5mg, 10mg, 15mg & 25mg.  Lenalid 5mg is a prescription medicine; used under the supervision of medical oncologist. Lenalid 5mg is used by combining with dexamethasone. INDICATION The most common indications of Lenalid 5mg Capsules are; Multiple myeloma: Lenalid 5mg capsules should be used in combination with dexamethasone. Myelodysplastic syndrome: Lenalid 5mg is used to treat this condition Mantle cell lymphoma: Lenalid 5mg is used for this condition, if patients are not responding to the Bortezomib treatment. Brand : Lenalid  Ingredients : Lenalidomide Strength : 5mg Manufactured : Natco Package : 30 Tablets DOSAGE MANAGEMENT

POMYELO 2MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomyelo 2mg and it belongs to anti-neoplastic drugs Pomyelo 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomyelo 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomyelo 2mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomyelo 2mg capsules is used by combining with dexamethasone. Pomyelo 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomyelo 2mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomyelo has three primary pharmacological activities

POMIRED 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomired 4mg and it belongs to anti-neoplastic drugs Pomired 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomired 4mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomired 4mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomired 4mg capsules is used by combining with dexamethasone. Pomired 4mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomired 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomired has three primary pharmacological activit